New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
NeuBase Therapeutics, Inc.
NBSE
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1M

Biotechnology

0.38USD
Shape-0.01 ( -1.56%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-30%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

91%

Quote Panel

Shape
Updated December 3, 2024
1W % 1M % 3M % 1Y -65.32 %

Key Metrics

Shape
  • Market Cap

    1.42M


  • Shares Outstanding

    3.75M


  • Share in Float

    3.30M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.378


  • Average Volume

    128236


  • Beta

    0.945


  • Range

    0.36-4.44


  • Industry

    Biotechnology


  • Website

    https://www.neubasetherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.11x

P/B Ratio

0.6

Debt/Equity

0.0%

Net Margin

$-18.6

EPS

How NBSE compares to sector?

P/E Ratio

Relative Strength

Shape

NBSE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10M

Shape25%

2025-Revenue

$2.42

Shape-26%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Oppenheimer

downgrade

Previous: Not converted

2022-10-21

Now: Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-4.80
vs -3.60

Q1.22

arrow
arrow

N/A

-6.00
vs -4.80

Q2.22

arrow
arrow

N/A

-5.20
vs -5.80

Q3.22

arrow
arrow

N/A

-4.80
vs -4.20

Q4.22

arrow
arrow

N/A

-2.60
vs -4.80

Q1.23

arrow
arrow

N/A

-2.40
vs -6.00

Q2.23

arrow
arrow

N/A

-1.26
vs -5.20

Q3.23

arrow
arrow

N/A

-0.95
vs -4.80

Q4.23

arrow
arrow

N/A

-2.00
vs -2.60

Q1.24

arrow
arrow

+165%

1.57
vs -2.40

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

NA

NA  vs NA

Q3.21

arrow
arrow

NA

NA  vs NA

Q4.21

arrow
arrow

NA

NA  vs NA

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

-16%

-0.16
vs -0.13

Q1.22

arrow
arrow

-26%

-0.26
vs -0.16

Q2.22

arrow
arrow

-28%

-0.28
vs -0.26

Q3.22

arrow
arrow

-33%

-0.33
vs -0.28

Q4.22

arrow
arrow

-28%

-0.28
vs -0.33

Q1.23

arrow
arrow

-28%

-0.28
vs -0.28

Q2.23

arrow
arrow

-31%

-0.31
vs -0.28

Q3.23

arrow
arrow

-20%

-0.20
vs -0.31

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

45

45
vs 49

-8%

Q1.22

arrow
arrow

44

44
vs 45

-2%

Q2.22

arrow
arrow

36

36
vs 44

-18%

Q3.22

arrow
arrow

36

36
vs 36

NA

Q4.22

arrow
arrow

32

32
vs 36

-11%

Q1.23

arrow
arrow

35

35
vs 32

9%

Q2.23

arrow
arrow

3

3
vs 35

-91%

Q3.23

arrow
arrow

1

1
vs 3

-67%

Earnings Growth

Latest News